PINDOLOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Pindolol, and what generic alternatives are available?
Pindolol is a drug marketed by Ani Pharms, Aurobindo Pharma Usa, Cosette, Mpp Pharma, Mylan Pharms Inc, Nostrum Labs, Purepac Pharm, Sun Pharm Industries, Unichem, Watson Labs, and Zydus Pharms. and is included in fourteen NDAs.
The generic ingredient in PINDOLOL is pindolol. There are eleven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the pindolol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pindolol
A generic version of PINDOLOL was approved as pindolol by AUROBINDO PHARMA USA on September 3rd, 1992.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PINDOLOL?
- What are the global sales for PINDOLOL?
- What is Average Wholesale Price for PINDOLOL?
Summary for PINDOLOL
| US Patents: | 0 |
| Applicants: | 11 |
| NDAs: | 14 |
| Finished Product Suppliers / Packagers: | 7 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 18 |
| Patent Applications: | 4,170 |
| Drug Prices: | Drug price information for PINDOLOL |
| DailyMed Link: | PINDOLOL at DailyMed |
Recent Clinical Trials for PINDOLOL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Actimed Therapeutics Ltd | PHASE2 |
| SCIRENT Clinical Research and Science d.o.o. | PHASE2 |
| Rawalpindi Medical College | Phase 3 |
Pharmacology for PINDOLOL
| Drug Class | beta-Adrenergic Blocker |
| Mechanism of Action | Adrenergic beta-Antagonists |
Medical Subject Heading (MeSH) Categories for PINDOLOL
Anatomical Therapeutic Chemical (ATC) Classes for PINDOLOL
US Patents and Regulatory Information for PINDOLOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ani Pharms | PINDOLOL | pindolol | TABLET;ORAL | 073609-002 | Mar 29, 1993 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Purepac Pharm | PINDOLOL | pindolol | TABLET;ORAL | 074125-002 | Apr 28, 1993 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Watson Labs | PINDOLOL | pindolol | TABLET;ORAL | 074437-002 | Feb 27, 1995 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Cosette | PINDOLOL | pindolol | TABLET;ORAL | 074123-001 | Apr 17, 1997 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Aurobindo Pharma Usa | PINDOLOL | pindolol | TABLET;ORAL | 074019-002 | Sep 3, 1992 | AB | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Mpp Pharma | PINDOLOL | pindolol | TABLET;ORAL | 205415-002 | Jan 13, 2016 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Sun Pharm Industries | PINDOLOL | pindolol | TABLET;ORAL | 074063-002 | Jan 27, 1994 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
